| PREDICTED MORTALITY AS A SURROGATE ENDPOINT IN THE PLCO TRIAL |
Matejka Rebolj |
Queen Mary University of London |
PLCO |
Oct 11, 2022 |
PLCO-1066 |
| Associations between lifestyle factors and colorectal cancer in the PLCO Cancer Screening Trial |
Kerrie Nelson |
Boston University |
PLCO |
Sep 21, 2022 |
PLCO-1053 |
| Class Project Reviewing Correlation between PSA and Prostate Cancer |
Mohamed Yaghi |
Mohamed Yaghi |
PLCO |
Sep 20, 2022 |
PLCO-1054 |
| Multivitamin use and mortality |
Erikka Loftfield |
Erikka Loftfield Cronin |
PLCO |
Sep 19, 2022 |
PLCO-1052 |
| A retrospective study on female-specific characteristics and their association to colorectal cancer using the PLCO Colorectal dataset |
Keerthana Clark |
Eastern Virginia Medical School |
PLCO |
Sep 9, 2022 |
PLCO-1043 |
| Correlates dietary and lifestyle patterns with survival in patients with gastrointestinal cancers |
Christina Grinstead |
University of Florida |
PLCO |
Sep 9, 2022 |
PLCO-1047 |
| Prostate Cancer Cohort Consortium (PC3): A collaborative approach to an enigmatic cancer |
Konrad Stopsack |
Harvard T.H. Chan School of Public Health |
PLCO |
Sep 9, 2022 |
PLCO-1046 |
| Aflatoxin, Polycyclic Aromatic Hydrocarbons, Heavy metals and DNA Methylation in Hepatocellular Carcinoma |
HuiChen Wu |
Columbia University |
PLCO |
Sep 7, 2022 |
2022-0003 |
| The timing between the diagnosis and the end of the last treatment in the cancer continuum in patients with lung cancer by TNM stages; and the impact of delays in the final survival of the patients, in PLCO, In the period available in the data set. |
Percy Guzman |
NCI |
PLCO |
Sep 6, 2022 |
PLCO-1036 |
| Post-diagnosis exercise and mortality risk in cancer survivors |
Jessica Gorzelitz |
University of Iowa |
PLCO |
Sep 6, 2022 |
PLCO-1032 |
| Prostate specific antigen volatility and the diagnosis of clinically significant prostate cancer |
John Leppert |
Stanford University |
PLCO |
Aug 29, 2022 |
PLCO-1034 |
| Metabolic health phenotypes, accelerated biological aging and cancer risk. |
Prasoona Karra |
Geisel School of Medicine at Dartmouth College |
PLCO |
Aug 29, 2022 |
PLCO-1028 |
| Use of PLCO data to evaluate the performance of cancer risk models |
Thomas Ahearn |
Division of Cancer Genetics and Epidemiology, NCI |
PLCO |
Aug 22, 2022 |
PLCO-1025 |
| Data Analysis of Male Breast Cancer |
Vaidehi Gajera |
Western Sydney University |
PLCO |
Aug 22, 2022 |
PLCO-1029 |
| Identifying risk factors for depression and the role of depression in cancer |
Lei Zhang |
Uniformed Services University |
PLCO |
Aug 22, 2022 |
PLCO-1027 |
| Prediction of Absolute Risk of Ovarian and Endometrial Cancer |
Sokbom Kang |
National Cancer Center, Korea |
PLCO |
Aug 22, 2022 |
PLCO-1023 |
| Determination of the association between BDNF, a potential biomarker, and depression in patients with cancer |
Lei Zhang |
Uniformed Services University |
PLCO |
Aug 22, 2022 |
PLCO-1021 |
| Fatty acids intake with emphasis on trans fatty acids and risks of Breast cancer and Colorectal Cancer |
Paolo Boffetta |
The Department of Medical and Surgical Sciences (DIMEC), the University of Bologna |
PLCO |
Aug 22, 2022 |
PLCO-1018 |
| Bladder Cancer Data Visualization |
OMAR GALDAMEZ CRUZ |
CENTRO DE DISEÑO Y COMUNICACION, S.C. |
PLCO |
Aug 2, 2022 |
PLCO-1011 |
| Prognostic factors in HER2-positive breast cancer |
Reem Chamseddine |
Weill Cornell Medicine-Qatar |
PLCO |
Aug 2, 2022 |
PLCO-1014 |
